The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.
Faloppi L, Bianconi M, Giampieri R, Sobrero A, Labianca R, Ferrari D, Barni S, Aitini E, Zaniboni A, Boni C, Caprioni F, Mosconi S, Fanello S, Berardi R, Bittoni A, Andrikou K, Cinquini M, Torri V, Scartozzi M, Cascinu S; Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Faloppi L, et al. Among authors: bianconi m.
Oncotarget. 2015 Oct 27;6(33):35087-94. doi: 10.18632/oncotarget.5197.
Oncotarget. 2015.
PMID: 26397228
Free PMC article.
Clinical Trial.